Source: Annual Congress 2011 - Experimental pulmonary hypertension
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
H. Karmouty-Quintana, H. Zhong, D. Zeng, L. Belardinelli, M. Blackburn (Houston, Palo Alto, United States Of America). Elevated levels of adenosine in the lungs lead to chronic lung injury and pulmonary hypertension. Eur Respir J 2011; 38: Suppl. 55, 3347

Member's Comments

No comment yet.

Related content which might interest you: Markers of pulmonary injury and inflammation are elevated in the serum of patients with chronic cough Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough Year: 2021 Suppressed pulmonary expression of leptin in lipopolysaccharide-induced acute and chronic lung inflammation Source: Annual Congress 2006 - Novel pathogenic aspects of acute lung injury and acute respiratory distress syndrome (ARDS) Year: 2006 The role of leptin in pulmonary neutrophilia during murine acute lung injury Source: Annual Congress 2011 - Lung cell injury and repair Year: 2011 Increased levels of oxidative stress markers in patients with idiopathic pulmonary fibrosis Source: International Congress 2016 – Common mechanisms in lung development and fibrosis Year: 2016 Elevated alveolar antioxidant levels in chronic fibrosing interstitial lung diseases Source: Annual Congress 2008 - New therapeutic strategies in idiopathic pulmonary fibrosis Year: 2008 Determination of pulmonary hypertension degree in patients with interstitial lung diseases Source: Annual Congress 2010 - Different patterns of interstitial lung disease Year: 2010 Blood MCP-1 levels are increased in chronic obstructive pulmonary disease with prevalent emphysema Source: International Congress 2018 – Biomarkers of COPD Year: 2018 Pulmonary hypertension in chronic lung disease and hypoxia Source: Eur Respir J, 53 (1) 1801914; 10.1183/13993003.01914-2018 Year: 2019 Nintedanib has acute pulmonary vasodilatory effects in transgenic Fra2 mice with spontaneous progressive pulmonary hypertension and lung fibrosis. Source: International Congress 2019 – Translational aspects of idiopathic pulmonary fibrosis Year: 2019 Acute hyperoxic challenge improves haemodynamics & Pulmonary vascular stiffness in interstitial lung disease-associated pulmonary hypertension Source: International Congress 2016 – Connective tissue disorders Year: 2016 Biomarkers in pulmonary hypertension associated to interstitial lung disease Source: Annual Congress 2010 - Pulmonary circulation II Year: 2010 Elevated circulating adiponectin levels in chronic thromboembolic pulmonary hypertension Source: Annual Congress 2010 - Pulmonary embolism Year: 2010 Therapeutic hypercapnia prevents pulmonary hypertension in rats with bleomycin-induced chronic neonatal lung injury Source: Annual Congress 2011 - Resuscitation and ventilation in the baby and infant Year: 2011 Reduced pulmonary vascular response to hypoxia is associated with endothelial dysfunction in chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 173s Year: 2001 The association between pulmonary arterial hypertension secondary to chronic lung disease and serum asymmetric dimethylarginine levels Source: Annual Congress 2012 - COPD comorbidities II Year: 2012 Effects of hypoxia-induced chronic changes in pulmonary haemodynamics on the lung function and responsiveness in rats Source: Annual Congress 2009 - Experimental approaches in animals and modelling in humans Year: 2009 Suppressed pulmonary expression of leptin in lipopolysaccharide-induced acute and chronic lung inflammation Source: Eur Respir Rev 2006; 15: 207-208 Year: 2006 Creatine supplementation attenuates systemic and pulmonary effects of acute lung injury induced by pulmonary ischemia-reperfusion in rats Source: Annual Congress 2012 - Lung transplantation: studies in candidates and recipients Year: 2012 Biomarkers for pulmonary hypertension in interstitial lung disease Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease Year: 2011 Pulmonary hypertensive vasculopathy in parenchymal lung diseases and/or hypoxia Source: Eur Respir Rev, 26 (144) 170003; 10.1183/16000617.0003-2017 Year: 2017